Search - tctmd.com

Displaying 101 - 120 of 488

Sort: Relevancy | Date

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis

Yael L. Maxwell

November 23, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Yael L. Maxwell

October 22, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

Caitlin E. Cox

September 01, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’

L.A. McKeown

August 28, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News ESC 2021

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Caitlin E. Cox

August 26, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

Advertisement

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Diabetes Progression in Statin-Treated Patients: VA Data

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content